Skip to main content
OpenTrials

Clinical trial condition

Myelodysplastic Syndromes

Explore clinical trials studying Myelodysplastic Syndromes. Study availability and eligibility vary by location and protocol.

696 public trials 122 recruiting studies
Refine in advanced search Browse all conditions

Myelodysplastic Syndromes trial results

Active, Not Recruiting

A Study of Tebapivat (AG-946) in Participants With Anemia Due to Lower-Risk Myelodysplastic Syndromes (LR-MDS)

NCT05490446

Conditions
Anemia, Bone Marrow Diseases, Hematologic Diseases, +2 more
Locations
  • Innovative Clinical Research Institute Whittier Lakewood, California, United States
  • David Geffen School of Medicine at UCLA Los Angeles, California, United States
  • Emad Ibrahim, MD, Inc. Redlands, California, United States
  • Smilow Cancer Hospital at Yale New Haven New Haven, Connecticut, United States
View all 45 locations
View Trial Details
Active, Not Recruiting

A Study of MGD024 in Patients With Relapsed or Refractory Hematologic Malignancies

NCT05362773

Conditions
Blastic Plasmacytoid Dendritic Cell Neoplasm, Bone Marrow Diseases, Chronic Disease, +37 more
Locations
  • Colorado Blood Cancer Network Denver, Colorado, United States
  • University of Maryland, Greenbaum Comprehensive Cancer Center Baltimore, Maryland, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • START - Midwest Grand Rapids, Michigan, United States
View Trial Details
Active, Not Recruiting

Roll-over Study for Patients Who Have Completed a Prior Novartis-sponsored Sabatolimab (MBG453) Study and Are Judged by the Investigator to Benefit From Continued Treatment With Sabatolimab.

NCT05201066

Conditions
Bone Marrow Diseases, Chronic Disease, Disease Attributes, +11 more
Locations
  • Oregon Health Sciences University Portland, Oregon, United States
  • Huntsman Cancer Institute Univ of Utah Salt Lake City, Utah, United States
  • Novartis Investigative Site Clayton, Victoria, Australia
  • Novartis Investigative Site Florianópolis, Santa Catarina, Brazil
View all 24 locations
View Trial Details
Active, Not Recruiting

Study to Evaluate Imetelstat (GRN163L) in Participants With International Prognostic Scoring System (IPSS) Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)

NCT02598661

Conditions
Bone Marrow Diseases, Disease Attributes, Hematologic Diseases, +5 more
Locations
  • UAB Comprehensive Cancer Center Birmingham, Alabama, United States
  • Acrc/Arizona Clinical Research, Inc. Tucson, Arizona, United States
  • CBCC Global Research, Inc. Bakersfield, California, United States
  • UCLA Ronald Regan Medical Center Los Angeles, California, United States
View all 126 locations
View Trial Details
Active, Not Recruiting

ELEMENT-MDS: A Study to Compare the Efficacy and Safety of Luspatercept in Participants With Myelodysplastic Syndrome (MDS) and Anemia Not Receiving Blood Transfusions

NCT05949684

Conditions
Anemia, Bone Marrow Diseases, Hematologic Diseases, +2 more
Locations
  • Local Institution - 0070 Clovis, California, United States
  • Local Institution - 0179 Fountain Valley, California, United States
  • Local Institution - 0211 Los Alamitos, California, United States
  • Local Institution - 0258 Los Angeles, California, United States
View all 144 locations
View Trial Details
Active, Not Recruiting

A Study to Assess Luspatercept in Lower-risk Myelodysplastic Syndrome Participants

NCT06045689

Conditions
Anemia, Bone Marrow Diseases, Hematologic Diseases, +2 more
Locations
  • Local Institution - 0051 Los Alamitos, California, United States
  • Local Institution - 0033 New Haven, Connecticut, United States
  • Local Institution - 0055 St. Petersburg, Florida, United States
  • Local Institution - 0056 Wellington, Florida, United States
View all 52 locations
View Trial Details

Related conditions